This text is a result of machine translation.
IntoCare Zhang Hui: Ingenuity Forges Quality, Continuous Improvement Safeguards Lives
In 2024, nearly all medical enterprises are exploring overseas markets. This trend is driven by an anti-corruption wave within the medical industry, the demand for financing and initial public offerings, as well as challenges such as excess production capacity. Presently, venturing abroad has become an essential developmental path for medical device enterprises. Successfully entering foreign markets is not only a crucial means for the medical industry to achieve a second grow
May 09, 2024 12:18 PM
Electric Vehicles to Account for Two-thirds of Global Vehicle Sales by 2030
Nullmax Launches 'Nullmax Intelligence': End-to-End Autonomous Driving Technology
Jul 19, 2024 10:23 AM
$42.5 Million Investment: Grupo Vazlo to Build Auto Parts Production Facility in Mexico
Tere Jiménez, the governor of Aguascalientes, Mexico, met with representatives of Grupo Vazlo, who announced a $42.5 million investment to build an auto parts manufacturing facility in the state. The first phase is expected to create 225 new jobs, enhancing Mexico's logistics and distribution capabilities for auto parts.
Jul 09, 2024 07:24 PM
We-Linking Raised Over CNY 10 Mn in Angel Round
Intraoperative Neurophysiological Monitoring Equipment Developer NeuroFlag Closed An Angel Round
Innovative Drug Developer Rezu Bio Raised CNY 10 Mn in Series Pre-A
Mexican Developer Finsa to Build Fifth Industrial Park in Nuevo León
Mexican real estate developer Finsa announced the construction of its fifth industrial park in Nuevo León, covering 79 hectares and expected to host 20 companies, creating around 35,000 jobs. The park will be part of Finsa's next generation of sustainable real estate, featuring circular economy initiatives like water recycling facilities and solar panels.
Jul 09, 2024 07:21 PM
CTTQ, Ampsourcebio Ink Agreement on Cure for NASH, T2DM
There are more than 95 plus major players and more than 90 plus nonalcoholic steatohepatitis (NASH) pipeline therapies, but none of them has been approved for marketing. Who would survive the competition in the blue-ocean market for NASH?
Apr 27, 2022 09:45 PM
China biopharmaceutical: the fifth indication of anti-tumor drug "arotinib hydrochloride capsule" has been approved
Jin Litai: the prices of various types of cathodic electrophoretic paint products rise by 10% - 20%